Novel class of PPAR agonists as hypoglycemic and hypotriglycerimic agents for type II diabetes (NIDDM).

被引:0
|
作者
Santini, C
Acton, JJ
Adams, AD
Aster, SD
Berger, GD
Dadiz, A
Graham, DW
Gratale, DF
Han, W
Jones, AB
Patel, GF
Sidler, K
Sahoo, SP
Von Langen, D
Yueh, W
Tolman, RL
Heck, JV
Liebowitz, MD
Berger, JP
Doebber, TW
Zhang, B
Moller, DE
Smith, RG
机构
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Mol Endocrinol, Rahway, NJ 07065 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
147-MEDI
引用
收藏
页码:U961 / U961
页数:1
相关论文
共 50 条
  • [1] Novel class of aryl thiazolidinedione PPAR agonists as insulin sensitizing agents for the treatment of Type II diabetes mellitus.
    Boueres, JK
    Han, W
    Santini, C
    Liang, CO
    Tolman, RL
    McNaul, KL
    Berger, JP
    Zhou, GC
    Doebber, TW
    Moller, DE
    Sahoo, SP
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U42 - U43
  • [2] ORAL HYPOGLYCEMIC AGENTS IN THE TREATMENT OF TYPE-II DIABETES
    TAL, A
    [J]. AMERICAN FAMILY PHYSICIAN, 1993, 48 (06) : 1089 - 1095
  • [3] Identification of Potential PPAR γ Agonists as Hypoglycemic Agents: Molecular Docking Approach
    Ganesh Prasad Mishra
    Rajesh Sharma
    [J]. Interdisciplinary Sciences: Computational Life Sciences, 2016, 8 : 220 - 228
  • [4] Identification of Potential PPAR γ Agonists as Hypoglycemic Agents: Molecular Docking Approach
    Mishra, Ganesh Prasad
    Sharma, Rajesh
    [J]. INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES, 2016, 8 (03) : 220 - 228
  • [5] ORAL HYPOGLYCEMIC AGENTS IN TYPE-II DIABETES-MELLITUS
    LUBBOS, H
    MILLER, JL
    ROSE, LI
    [J]. AMERICAN FAMILY PHYSICIAN, 1995, 52 (07) : 2075 - 2078
  • [6] Discovery of a novel class of PPARδ partial agonists
    Shearer, Barry G.
    Patel, Hari S.
    Billin, Andrew N.
    Way, James M.
    Winegar, Deborah A.
    Lambert, Millard H.
    Xu, Robert X.
    Leesnitzer, Lisa M.
    Merrihew, Raymond V.
    Huet, Stephane
    Willson, Timothy M.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (18) : 5018 - 5022
  • [7] PPAR-α and PPAR-γ agonists for type 2 diabetes
    Charbonnel, Bernard
    [J]. LANCET, 2009, 374 (9684): : 96 - 98
  • [8] Novel pan PPAR Agonists are promising drugs for the treatment of type 2 diabetes
    Perreault, Mylene
    Jalenak, Mary
    Panza, Darrell A.
    Will, Sarah
    Artis, Rick
    Bollag, Gideon
    Ibrahim, Prabha
    Lin, Jack
    Klaman, Lori D.
    Tobin, James F.
    [J]. DIABETES, 2006, 55 : A478 - A478
  • [9] Design and synthesis of a novel class of dual PPARγ/δ agonists
    Gonzalez, Isabel C.
    Lamar, Jason
    Iradier, Fatima
    Xu, Yanping
    Winneroski, Leonard L.
    York, Jeremy
    Yumibe, Nathan
    Zink, Richard
    Montrose-Rafizadeh, Chahrzad
    Etgen, Gary J.
    Broderick, Carol L.
    Oldham, Brian A.
    Mantlo, Nathan
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (04) : 1052 - 1055
  • [10] Selective PPAR Agonists for the Treatment of Type 2 Diabetes
    Nehlin, Jan O.
    Mogensen, John P.
    Petterson, Ingrid
    Jeppesen, Lone
    Fleckner, Jan
    Wulff, Erik M.
    Sauerberg, Per
    [J]. UNDERSTANDING AND MODULATING AGING, 2006, 1067 : 448 - 453